Monte Rosa Therapeutics (GLUE)
(Delayed Data from NSDQ)
$4.85 USD
-0.33 (-6.37%)
Updated May 10, 2024 03:59 PM ET
After-Market: $4.83 -0.02 (-0.41%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.59 | 0.00% |
Earnings Summary
For their last quarter, Monte Rosa Therapeutics (GLUE) reported earnings of -$0.53 per share, beating the Zacks Consensus Estimate of $-0.56 per share. This reflects a positive earnings surprise of 5.36%. Look out for GLUE's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.59 per share, reflecting a year-over-year increase of 16.9%.
Earnings History
Price & Consensus
Zacks News for GLUE
Does Monte Rosa Therapeutics (GLUE) Have the Potential to Rally 107.79% as Wall Street Analysts Expect?
GLUE: What are Zacks experts saying now?
Zacks Private Portfolio Services